Top Markets
#1 Nesa Nesa +784.25%
#2 Cortex Cortex +68.84%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.78%
#4 Pons Pons +27.19%
#5 QuantixAI QuantixAI +23.56%
#6 EXOD EXOD +22.78%
#7 Instadapp Instadapp +16.15%
#8 Movement Movement +15.14%
#9 OpenEden OpenEden +13.93%
#10 The Black Bull The Black Bull +13.02%
Coin of the day
Nesa Nesa
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen Salubris Pharmaceuticals Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

002294
Clasificación en acciones #3524
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Precio por acción
$4.65
Capitalización bursátil
$5.18B
Cambio (1 día)
0.47%
Cambio (1 año)
-37.38%
País
CN
Comercio Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)

Categoría

Healthcare
Historial de dividendos de Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Shenzhen Salubris Pharmaceuticals Co., Ltd. (símbolo bursátil: 002294) realizó un total de 0 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: 0.00
Rentabilidad por dividendo (TTM): 0
Pagos de dividendos de Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) desde 2026 hasta 2026
Pagos anuales de dividendos
Año Dividendo (ajustado por splits de acciones) Cambiar
Not enough data for the provided dates.
Lista de todos los pagos de dividendos
Año Dividendo Cambiar
Not enough data for the provided dates.
Pagos de dividendos de empresas similares o competidoras
Empresa Número de pagos de dividendos País
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
0.00%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
26.00%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
0.00%
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
173.00%
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
0.00%
CH